NEO

NeoGenomics Inc.

Price

$15.67

return (12m)

203.68%

p/e

-39.27

p/bv

2.59

DIVIDEND YIELD

0.00%

NEO price

NeoGenomics

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment NEO

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

3.36%

3 months

66.00%

1 year

203.68%

2 years

-10.46%

5 years

-66.07%

10 years

89.80%

Fundamentals NEO

Valuation

P/E

-39.27

Sector -25.47

Industry -78.47

P/BV

2.59

Sector 1.57

Industry 1.52

P/Revenue (PSR)

2.66

Sector 1.91

Industry 0.57

EV/EBITDA

120.39

Sector -46,817,877.85

Industry -1,970,485.84

EV/EBIT

868.12

Sector -52,924,297.69

Industry -8,660,515.04

P/EBITDA

151.01

Sector -11.28

Industry -69.96

P/EBIT

-39.20

Sector -11.32

Industry -56.13

P/Total Assets

1.51

Sector 0.91

Industry 0.61

P/Net Current Assets

-11.01

Sector -7,795,119.74

Industry -34,595,605.40

P/Working Capital

7.39

Sector -476,039.66

Industry -3,983,001.86

EPS

-0.40

Sector -2.31

Industry -1.74

BVPS

6.04

Sector 2.47

Industry 2.82

Efficiency

Gross Margin

43.92%

Sector 36.51%

Industry 23.03%

EBITDA Margin

9.33%

Sector -352.48%

Industry -76.74%

EBIT Margin

1.29%

Sector -207.71%

Industry -12.19%

Operating Margin

-7.93%

Sector -40.84%

Industry -26.63%

Net Profit Margins

-6.77%

Sector -44.42%

Industry -35.63%

Asset Turnover

0.15

Sector 0.12

Industry 0.22

Profitability

ROE

-6.60%

Sector -100.16%

Industry -133.08%

ROA

-3.84%

Sector -57.20%

Industry -44.82%

ROIC

-3.36%

Sector -439.03%

Industry -111.96%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

3.60

Sector 1.87

Industry 1.10

Net Debt / EBITDA

12.15

Sector -1.58

Industry -28.84

Net Debt / EBIT

87.62

Sector -0.83

Industry 3.17

Net Debt / Equity

0.29

Sector -0.36

Industry 0.13

Gross Debt / Equity

0.48

Sector 0.16

Industry 0.51

Equity/Assets

0.58

Sector 0.29

Industry 0.18

Liabilities/Assets

0.42

Sector 0.37

Industry 0.30

Growth

5Y Revenue CAGR

9.61%

Sector -

Industry -

5Y Earnings CAGR

44.10%

Sector -

Industry -

Fundamentals NEO

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
NEO	-39.27	2.59	-6.60%	0.00%	$2.04 B	-6.77%
DGX	23.82	3.20	13.44%	1.46%	$25.30 B	9.19%
STRRP	8.16	2.56	31.31%	9.43%	$163.57 M	25.96%
ENSG	27.16	4.21	15.49%	0.14%	$10.29 B	6.90%
CRVL	27.65	7.74	27.99%	0.00%	$3.05 B	11.51%
JYNT	36.27	7.59	20.92%	0.00%	$117.53 M	5.72%
OPCH	16.62	2.76	16.63%	0.00%	$3.48 B	3.68%
MGLN	8.00	1.53	19.13%	0.00%	$2.42 B	6.38%
PGNY	37.26	5.74	15.40%	0.00%	$2.52 B	5.23%
VAR	58.58	7.26	12.40%	0.00%	$16.26 B	5.85%
PNTG	46.42	3.61	7.79%	0.00%	$1.41 B	2.96%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

NEO Historical Dividends

current DY: 0.00%

5-year average DY: 0.23%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	12/16/2020	12/30/2020	0.40000000

ABOUT NeoGenomics

NeoGenomics Inc.

Average Investor10 user rating

4.0 (1 people)

United States

28 years

Founded: 1998

1996

Time since IPO - 30 years

1.700

Employees

NeoGenomics Inc. (United States) is listed on the Nasdaq and has a market capitalization of $2.04 billion, with shareholders equity totaling $785.73 million.

The company employs approximately 1.700 people and operates in the Health sector, within the Health Establishments industry.

Over the past 12 months, NeoGenomics Inc. reported $766.30 million in revenue, generating net income of $-51.88 million.

Key financial metrics include a P/E ratio of -39.27, a price-to-book (P/B) ratio of 2.59, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker NEO.

Market cap

$2.04 billion

Net worth

$785.73 million

$785,730,000.00

Assets

$1.35 billion

$1,352,240,000.00

Total Shares Outstanding

130.00 million

130,000,000

Average Daily Trading Volume

$3.00 million

$3,003,484.00

Sector

Health

Industry

Health Establishments

NEO

NEO revenue and profits

Financial Results NEO

DRAG THE FRAME TO SEE MORE DATA

NEO cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

0.00%

ROE

P/BV

0.00

BDXB - Becton Dickinson

$- -0,00% (12M)

P/E

8.75

0.00%

ROE

6.12%

P/BV

0.54

VTRS - Viatris

$17.53 106,78% (12M)

P/E

-68.27

2.74%

ROE

-2.02%

P/BV

1.38

HSIC - Henry Schein

$85.60 25,91% (12M)

P/E

24.92

0.00%

ROE

8.19%

P/BV

2.04

ISRG - Intuitive Surgical

$352.33 --27,07% (12M)

P/E

39.74

0.00%

ROE

What is the price of NeoGenomics (NEO) today?

A cotação de NeoGenomics (NEO) hoje está em US$ 15.67, com uma variação de 203.68% em relação ao último ano. A cotação de NeoGenomics (NEO) iniciou o ano negociando na casa dos US$ 11.76 e hoje está em US$ 15.67. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de NeoGenomics (NEO) e dados de ações do Ibovespa e mercados internacionais.

Quando NeoGenomics (NEO) paga dividendos?

NeoGenomics (NEO) não distribuiu dividendos no último ano.

Is NeoGenomics (NEO) a good investment?

Atualmente, NeoGenomics (NEO) está cotada a US$ 15.67, com um P/L de -39.27, representando um desvio de -2,247% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 203.68 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 203.68%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy NeoGenomics (NEO) stock?

Investir em ações de NeoGenomics (NEO) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of NeoGenomics (NEO) yield today?

A rentabilidade de NeoGenomics (NEO) foi de 3.36% no último mês, 203.68% no último ano e -66.07% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de NeoGenomics (NEO) hoje, o investimento total seria de US$ 1,567.00, com base na cotação atual de US$ 15.67.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 4,758.67
Em 5 anos: US$ 531.68
Em 10 anos: US$ 2,974.17

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

NEO

NeoGenomics Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment NEO

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

current DY: 0.00%

5-year average DY: 0.23%

type

Ex - Dividend Date

payment date

value

ABOUT NeoGenomics

NeoGenomics Inc.

United States

28 years

1996

1.700

PROFIT X PRICE NEO

Financial Results NEO

NEO cash flow

Asset, Revenue and Profit Growth - NEO

NEO balance sheet

CI - Cigna

SNY - Sanofi

ABT - Abbott